Homoveratrylamine

Specifications

120-20-7CAS Number

204-376-9EC Number

2-(3,4-dimethoxyphenyl)ethanamineIUPAC Name

C10H15NO2Chemical Formula

181.23 g/molMolecular Weight

3,4-Dimethoxyphenethylamine; 120-20-7; Homoveratrylamine; 3,4-Dimethoxyphenylethylamine; 2-(3,4-Dimethoxyphenyl)ethylamine; Benzeneethanamine, 3,4-dimethoxy-; Dimethoxydopamine; Dimethylmescaline; DMPEA; 3,4-Dimethoxybenzeneethanamine; Dopamine dimethyl ether; DIMPEA; O,O-Dimethyldopamine; 3,4-Di-O-methyldopamine; 3,4-Dimethoxydopamine; 2-(3,4-Dimethoxyphenyl)Ethan-1-Amine; 3,4-Dimethoxyphenylethylamine(base); 3,4-Dimethoxy-beta-phenylethylamine; beta-(3,4-Dimethyoxyphenyl)ethylamine; NSC 16948; 2-(3,4-Dimethoxy-phenyl)-ethylamine; PHENETHYLAMINE, 3,4-DIMETHOXY-; EINECS 204-376-9; IQF9T435OP; 3,4-Dimethoxyphenylethylamine (base); 3,4-Dimethoxy-.beta.-phenylethylamine; BRN 0474393; AI3-23876; CHEBI:136995; NSC-6328; NSC-16948; NSC-26152; DOPAMINE IMPURITY C; DTXSID8059506; EC 204-376-9; 4-13-00-02604 (Beilstein Handbook Reference); 2-(3,4-dimethoxyphenyl) ethylamine; DOPAMINE HYDROCHLORIDE IMPURITY C [EP IMPURITY]; DOPAMINE HYDROCHLORIDE IMPURITY C (EP IMPURITY); O,ODimethyldopamine; 3,4Dimethoxydopamine; 3,4DiOmethyldopamine; HOMOVERATRILAMINE; RefChem:788471; 3,4dimethoxyphenethylamine; 3,4Dimethoxyphenylethylamine; 3,4Dimethoxybenzeneethanamine; Phenethylamine, 3,4dimethoxy; 3,4Dimethoxybetaphenylethylamine; Benzeneethanamine, 3,4dimethoxy; DTXCID6033530; 2(3,4Dimethoxyphenyl)ethylamine; beta(3,4Dimethoxyphenyl)ethylamine; 3,4Dimethoxyphenylethylamine (base); InChI=1/C10H15NO2/c1-12-9-4-3-8(5-6-11)7-10(9)13-2/h3-4,7H,5-6,11H2,1-2H; 2-(3,4-Dimethoxyphenyl)ethanamine; Dopamine EP Impurity C; 2-(3,4-dimethoxyphenyl)-ethylamine; 3,4-dimethoxy phenylethylamine; 3,4-Dimethoxypheneethylamine; 3,4-dimethyloxyphenylethylamine; 3,4-Dimethoxy-.beta.-phenethylamine; beta-(3,4-Dimethoxyphenyl)ethylamine; .beta.-(3,4-Dimethoxyphenyl)ethylamine; Phenethylamine,4-dimethoxy-; Benzeneethanamine,4-dimethoxy-; WLN: Z2R CO1 DO1; 3,4-Dimethoxy phenethylamine; MFCD00008188; SMR000112358; UNII-IQF9T435OP; homoveratryl amine; Dopamine Impurity C (3,4-Dimethoxyphenethylamine); 3,4-DIMETHOXY-PHENETHYLAMINE; 2-(3,4-Dimethoxyphenyl)-1-aminoethane; Tetrabenazine Impurity N4; Epitope ID:119694; NCIOpen2_005995; Oprea1_397610; 3, 4-Dimethoxyphenethylamine; MLS000515889; MLS001424180; CHEMBL26019; SCHEMBL210639; 3,4-di-methoxy-phenethylamine; 3,4-dimethyoxyphenylethylamine; 3,4-dimethoxy-phenylethylamine; 3,4-Dimethoxy-Benzenethanamine; orb1298183; SCHEMBL1148327; SCHEMBL7319619; 3, 4-Dimethoxybenzeneethanamine; b-3,4-dimethoxyphenylethylamine; 3,4-Dimethoxy-Benzeneethanamine; Phenethyl amine, 3,4-dimethoxy; SCHEMBL27420720; SCHEMBL28007523; SCHEMBL29351641; NSC6328; 2(3,4-dimethoxyphenyl)ethylamine; Benzenethanamine, 3,4-dimethoxy-; 3,4-Dimethoxy-beta-phenethylamine; b-(3,4-dimethoxyphenyl)ethylamine; HMS2052A09; HMS2269O22; HMS3394A09; 3,4-Dimethoxyphenethylamine, 97%; 3, 4-Dimethoxy-beta-phenethylamine; HY-Y0935; MBA69947; NSC16948; NSC26152; b-(3,4-dimethoxyphenyl)ethyl amine; 2-(3,4-dimethoxy-phenyl)ethylamine; BBL023006; EBC-03544; SBB008220; STK397473; 3, 4-Dimethoxy-beta-phenylethylamine; 3, 4-Dimethoxyphenylethylamine(base); 3,4-dimethoxy-beta-phenyl-ethylamine; [2-(3,4-dimethoxyphenyl)ethyl]amine; 2-(3,4-dimethoxy-phenyl)ethyl amine; 2-(3,4-Dimethoxyphenyl)ethanamine #; AKOS000104026; beta-(3,4-dimethoxyphenyl)-ethylamine; AC-8488; CCG-101095; CS-W023192; FH23862; FS-4041; NC00345; 2-(3',4'-dimethoxyphenyl)-ethylamine; beta-(3,4 -dimethoxyphenyl) ethylamine; NCGC00247022-01; DB-001827; DB-003355; D0678; NS00004795; ST45026146; T9326; EN300-20212; F008886; Q4634069; 2-(3,4-Dimethoxyphenyl)ethanamine (ACD/Name 4.0); 2-(3,4-Dimethoxyphenyl)ethylamine (ACD/Name 4.0); BRD-K59570838-003-01-9; F2190-0398; Z104477298Synonyms